Corona releases global film to mark its centennial anniversary

Michel Doukeris CEO Anheuser-Busch InBev SA/NV
Michel Doukeris CEO - Anheuser-Busch InBev SA/NV
0Comments

Corona is marking its 100th anniversary by launching a new film, “100 Years of Living,” as part of the brand’s Corona 100 platform. The film features real individuals who embody what the company calls “The Corona Way”—a lifestyle centered on nature, relaxation, and spending time outdoors.

Richard Oppy, Global President, Premium Co. at AB InBev, commented on the campaign: “Thisnew 100 Years of Living campaign, launched in a year when the brand is celebrating its 100th anniversary, is a powerful expression of ‘The Corona Way’ of living – rooted in nature, relaxation, and time well spent outdoors,” said Richard Oppy, Global President, Premium Co. at AB InBev, brewer of Corona. “With this film, we’re proud to recognize those that have embraced this way of life for decades. Their stories serve as an inspiration for the millions around the world who also feel most at home in nature with a Corona in hand.”

The film will be distributed globally through television, digital channels, social media platforms, print publications, radio broadcasts and out-of-home advertising.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.